Results 31 to 40 of about 3,816 (188)
Counterfeit Healthcare Products: Nepal at a Vulnerable Position
Journal of Nepal Medical Association, 2022 Nepal stands in a vulnerable position when it comes to counterfeit medicines as two of its major trade partners countries are leading producers of falsified healthcare products. The impacts that it can lead to are a lower standard of healthcare delivery
Bijay Bhandari, Gaurav Rayamajhi
doaj +1 more source
Nature Communications, 2023 Approximately 10% of antimicrobials used by humans in low- and middle-income countries are estimated to be substandard or falsified. In addition to their negative impact on morbidity and mortality, they may also be important drivers of antimicrobial ...
Sean Cavany +9 more
doaj +1 more source
Medicine quality in high-income countries: The obstacles to comparative prevalence studies
Medicine Access @ Point of Care, 2021 The entry of falsified and substandard medicines into the legitimate pharmaceutical supply chain has negative impacts on healthcare systems, patient safety, and patient access to medicine. The COVID-19 pandemic has highlighted the importance of access to
Bernard David Naughton, Ebru Akgul
doaj +1 more source
Quality of Drug in Health Facilities: A Cross-sectional Study
Journal of Nepal Health Research Council, 2021 Background: Poor quality drugs result minor to detrimental effect on human health. The drug should be of standard quality and should be used appropriately in order to meet its therapeutic efficacy. This study aims to assess the quality of drug in Nepal.
Khem Bahadur Karki +5 more
doaj +1 more source
Commentary: Substandard medicines are the priority for neglected tropical diseases [PDF]
BMJ, 2012 Attaran and colleagues propose new definitions for the quality of medicines and plead for a global treaty tackling both substandard production and falsification.1 We support this, as the international community tends to concentrate its efforts on falsified medicines, whereas substandard drugs are just as much a threat.2 Moreover, in practice the ...
Dorlo, T. P. C. +3 more
openaire +4 more sources
PLOS Global Public Health, 2023 Essential medicines are those medicines that satisfy the primary health care needs of the citizens. Poor quality of essential medicines can have serious impact on public health.
Neelam Dhakal +8 more
doaj +2 more sources
Importance of medicine quality in achieving universal health coverage.
PLoS ONE, 2020 ObjectiveTo assess the importance of ensuring medicine quality in order to achieve universal health coverage (UHC).MethodsWe developed a systems map connecting medicines quality assurance systems with UHC goals to illustrate the ensuing impact of quality-
Sachiko Ozawa +6 more
doaj +1 more source
INNOVATIONS in Pharmacy, 2021 Substandard and counterfeit medicines (SCMs) are a major public health threat in Africa. In Nigeria, the manufacture and distribution of substandard and counterfeit medicines in the drug market are booming, despite the efforts of law enforcement agencies
Melody Okereke +3 more
doaj +1 more source
How to achieve international action on falsified and substandard medicines [PDF]
BMJ, 2012 Substandard and falsified medicines kill patients, yet progress on the twin challenges of safeguarding the quality of genuine medicine and criminalising falsified ones has been held back by controversy over intellectual property rights and confusion over terms.
Attaran, A +13 more
openaire +4 more sources
Substandard and falsified medicines
JMIR Public Health and Surveillance, 2021 The World Health Organization and others warn that substandard and falsified medicines harm health and waste money, especially in low- and middle-income countries. However, no country has measured the market-wide extent of the problem, and no standardized methods exist to estimate the prevalence of either substandard or falsified medicines. This is, in
Pisani, Elizabeth +5 more
openaire +2 more sources